Antitumor activity of taxane chemotherapy as first subsequent therapy after abiraterone acetate (AA) in study COU-AA-302 for metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Ryan, C. J.; de Bono, J. S.; Smith, M. R.; Rathkopf, D. E.; Mulders, P. F. A.; Small, E. J.; Shore, N. D.; Fizazi, K.; De Porre, P.; Kheoh, T.; Li, J. H.; Todd, M. B.; Griffin, T. W.; Saad, F. |
| Abstract Title: | Antitumor activity of taxane chemotherapy as first subsequent therapy after abiraterone acetate (AA) in study COU-AA-302 for metastatic castration-resistant prostate cancer (mCRPC) |
| Meeting Title: | 2nd Prostate Cancer World Congress (PCWC) |
| Journal Title: | BJU International |
| Volume: | 116 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2015 Aug 17-21 |
| Meeting Location: | Cairns, Australia |
| ISSN: | 1464-4096 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2015-08-01 |
| Start Page: | 12 |
| Language: | English |
| ACCESSION: | WOS:000359254200033 |
| PROVIDER: | wos |
| PUBMED: | 26250590 |
| DOI: | 10.1111/bju.13198 |
| Notes: | Meeting Abstract: 088 -- Source: Wos |
